Karin Eastham - 18 Jun 2026 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Reporting relationship: Director
Issuer ticker: VCYT
Reported as of: 18 Jun 2026
Net transaction value: -$197,234
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:30:54 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Wygant as attorney-in-fact

Key filing fact

Karin Eastham filed Form 4 for VERACYTE, INC. (VCYT) on 22 Jun 2026.

Key facts

This page summarizes Karin Eastham's Form 4 filing for VERACYTE, INC. (VCYT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 16:30.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: -$197,234.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001231845 Primary reporting owner

EASTHAM KARIN

Relationship: Director
Address: 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Jonathan Wygant as attorney-in-fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Sale

Transaction value: $168,906
Shares: -3,200
Change %: -17%
Price: $52.78
Shares after: 15,626
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1, F2

VCYT transaction

Common Stock

Sale

Transaction value: $28,328
Shares: -529
Change %: -3.4%
Price: $53.55
Shares after: 15,097
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025.

Footnote F2

Represents weighted average sales price. Sale prices for the transactions range from $52.26 to $53.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F3

Represents weighted average sales price. Sale prices for the transactions range from $53.29 to $53.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.